BPC-157, a synthetic peptide with regenerative and cytoprotective properties, has been the subject of extensive preclinical research. While there are no well-established human drug interactions for BPC-157, several theoretical and animal-based interactions have been identified that warrant careful consideration. These include potential interactions with insulin and diabetes medications, alcohol, corticosteroids, NSAIDs, blood pressure medications, and anticoagulants/antiplatelets. However, it is crucial to note that these interactions are largely based on animal studies and theoretical extrapolations, with minimal human safety data available.
What the AI assistants say
The AI assistants collectively agree that there are no robust, clinically confirmed drug interactions with BPC-157 in humans. They highlight that the evidence base for these interactions is predominantly preclinical (animal/in vitro), with only minimal human safety data. The AI assistants identify several key areas of potential interaction:
- Insulin & Diabetes Medications: BPC-157 may counteract insulin-induced hypoglycemia through glycogen preservation and glucose metabolism modulation. This is based on animal studies, with no human evidence available.
- Alcohol: BPC-157 interacts with the nitric oxide (NO) system, potentially affecting both acute alcohol intoxication and withdrawal symptoms. Again, this is based on animal studies, with no published human evidence.
- Corticosteroids: BPC-157 has been shown to reverse corticosteroid-impaired muscle healing in animal models, suggesting a potentially beneficial interaction for healing, but this is not established in humans.
- NSAIDs: BPC-157 may counteract NSAID-induced GI lesions and other toxic effects in animals, but this has not been proven in humans.
- Blood Pressure Medications: Theoretical interactions are possible due to BPC-157’s effects on nitric oxide production and vasodilation, but there is no documented human evidence.
- Anticoagulants/Antiplatelets: BPC-157 may counteract aspirin-induced prolonged bleeding and thrombocytopenia in animal models, but this interaction is not well established in humans.
The AI assistants differ in their emphasis on the strength of the evidence for these interactions, with some highlighting the strong animal evidence for certain interactions, while others focus on the lack of human data and the theoretical nature of these potential interactions.
What the research actually shows
The research corpus supports the AI assistants’ consensus that there are no well-established human drug interactions for BPC-157. However, it provides additional insights into the potential interactions based on preclinical studies:
- Interaction with Anticoagulants and Antiplatelet Agents: [2] discusses the interaction of BPC-157 with heparin, warfarin, and aspirin, suggesting that BPC-157 may have a cytoprotective effect on the endothelium and wound healing properties, which could impact bleeding and the effects of anticoagulants and antiplatelet agents.
- Interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): [17] mentions that BPC-157 may counteract the complex toxicity of NSAIDs, such as diclofenac, suggesting a potential protective role against gastrointestinal damage associated with these drugs.
- Interaction with Ethanol: [20] refers to the influence of BPC-157 on acute and chronic ethanol administration in mice, implying potential interactions with alcohol or drugs with ethanol as a component.
- Interaction with Nitric Oxide (NO) System: [7] and [15] discuss the interaction of BPC-157 with the NO system, suggesting that BPC-157 could have interactions with drugs that affect the NO system, which plays a role in vascular function and inflammation.
- Interaction with Dopaminergic and Adrenergic Systems: [9] and [10] suggest that BPC-157 has particular connections with the adrenergic and dopaminergic systems, providing a basis for further investigation into its interactions with drugs targeting these systems.
- Interaction with Capsaicin-Sensitive Neurons: [9] also mentions a close interaction between BPC-157 and capsaicin-sensitive neurons, suggesting potential interactions with drugs that affect pain perception and neurotransmission.
The research corpus underscores the need for further investigation into the extent and clinical significance of these interactions, as the current evidence is predominantly based on animal studies and theoretical considerations.
Bottom Line:
Bottom line: While there are no well-established human drug interactions for BPC-157, several theoretical and animal-based interactions have been identified that warrant further investigation to understand their potential impact on drug efficacy and safety.
References
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Pentadecapeptide BPC 157 Interactions with Adrenergic and — Vjekoslav Jagic
- Pentadecapeptide BPC 157 reduces bleeding time and — Mirjana Stupnisek
- Peptide Protocols Volume One — William A Seeds MD
- Peptide Therapeutics_ Design and Development
- Peptide drug discovery and development _ Translational — edited by Miguel Castanho and
- Peptide therapy with pentadecapeptide BPC 157 in traumatic — Gjurasin, Miroslav
- Peptides_ Chemistry and Biology, 2nd Edition
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor
Continue your research
Part of our BPC-157: Safety, Side Effects & Regulation guide.
- What are the known side effects of BPC-157 in humans?
- Does BPC-157 increase cancer risk because of its angiogenic (blood-vessel-growing) effects?
- Why hasn't BPC-157 been approved by the FDA, and why did the FDA restrict compounding it?
- Is BPC-157 banned by WADA for athletes, and why?
Related topics:
- Is there any evidence that BPC-157 helps bone fractures heal?
- Have there been any human clinical trials of BPC-157, and what did they find?
- Is there evidence BPC-157 protects against stroke damage or aids recovery after stroke?